SCHEMBL1832489

SCHEMBL1832489

Fc1ccccc1-c1ccnc2c1CN(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)CCCCO2

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 11/20 0.64
ADRB2 P07550 1/20 0.64
FPR1 P21462 1/20 0.64
GPR183 P32249 1/20 0.64
APLNR P35414 1/20 0.64
GLP1R P43220 1/20 0.64
GPR35 Q9HC97 1/20 0.64
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 2/20 0.38
GAA P10253 1/20 0.38
GRM2 Q14416 1/20 0.37
CASP1 P29466 1/20 0.36
CASP5 P51878 1/20 0.36
CYP2D6 P10635 3/20 0.35
CYP3A4 P08684 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34
DRD3 P35462 1/20 0.34
CLPP Q16740 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1834172 0.93 GPBAR1 (0.67) GPBAR1ADRB2FPR1GPR183APLNR
SCHEMBL1839636 0.89 GPBAR1 (0.49) GPBAR1ADRB2FPR1GPR183APLNR
SCHEMBL1835835 0.86 ADRB2 (0.47) GPBAR1ADRB2FPR1GPR183APLNR
SCHEMBL1834917 0.83 GPBAR1 (0.55) GPBAR1ADRB2FPR1GPR183APLNR
SCHEMBL1837939 0.83 ADRB2 (0.47) GPBAR1ADRB2FPR1GPR183APLNR
SCHEMBL1832880 0.83 GPBAR1 (0.54) GPBAR1ADRB2FPR1GPR183APLNR
SCHEMBL1835421 0.82 ADRB2 (0.49) GPBAR1ADRB2FPR1GPR183APLNR
SCHEMBL1951653 0.81 GPBAR1 (0.52) GPBAR1ADRB2FPR1GPR183APLNR
Sulfuric Acid SCHEMBL4506000 0.81 GPBAR1 (0.48) GPBAR1ADRB2FPR1GPR183APLNR
SCHEMBL1837407 0.80 GPBAR1 (0.54) GPBAR1ADRB2FPR1GPR183APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2322222-A1 THERAPEUTIC AGENT FOR IRRITABLE BOWEL SYNDROME Takeda Pharmaceutical Company Limited (JP) 2011-05-18 EP disclosed